News
Spent embryo culture medium carries RNA that tracks chromosome status, Nature Cell Biology study finds

· IVF Automation News
Summary
A Japanese team has sequenced the full set of RNA inside individual human blastocysts and in the culture medium each embryo grew in. Published in Nature Cell Biology on 9 November 2026, the study found that RNA in the spent medium of euploid embryos closely mirrored the RNA inside them, while aneuploid embryos released a less consistent profile with signs of cellular stress. The authors present the work as a research resource and a foundation for non-invasive embryo assessment. It did not measure pregnancy or live birth, so it is not a clinical test.
Spent culture medium is normally discarded once an embryo has been assessed. This study asks whether that medium holds RNA signals of an embryo’s state, and finds that it may.
What did the researchers do?
The group, from Fujita Health University, Sapporo Medical University, Kobe Motomachi Yume Clinic and the University of Yamanashi, used 58 frozen embryos donated for research with written consent by 35 patients who had undergone PGT-A, according to Sapporo Medical University’s press release. Each embryo was cultured on its own for 24 hours, and the embryo and its medium were collected separately.
They used a full-length total RNA sequencing method (RamDA-seq) that can read very small amounts of RNA. Chromosome status came from conventional biopsy-based testing. The main analysis compared 19 euploid and 33 aneuploid embryos with their matched media, 103 datasets in all. To avoid contamination from maternal cells, the zona pellucida was removed, a research-only step.
What did they find?
In euploid embryos, RNA levels inside the embryo and in the medium lined up closely (correlation coefficient 0.862). In aneuploid embryos the match was weaker (0.639), the press release reports.
RNA released steadily by euploid embryos was enriched for genes involved in vesicle transport and autophagy. The authors read this as a sign that embryos actively export RNA, rather than it simply leaking from dying cells. Aneuploid embryos showed stress-linked signatures, including nonsense-mediated decay, the cell’s system for destroying faulty RNA, and TP53-mediated apoptosis, a programme that removes abnormal cells.
In mouse embryos, blocking autophagy with chloroquine changed the RNA profile in the medium, supporting a link between the embryo’s internal recycling machinery and what it releases.
Why does RNA matter when DNA tests already exist?
Non-invasive PGT has so far focused mainly on cell-free DNA in spent medium. The press release notes that DNA is released mostly when cells break down, and that agreement between medium-based and biopsy results has been reported at around 80%. RNA reflects which genes are active at the time, so the authors argue it could show an embryo’s current state, not just its chromosome count.
What does it mean for embryologists and lab managers?
- No change to practice yet. The study did not link RNA profiles to implantation, pregnancy or live birth, and used zona-free embryos, which is not standard clinical culture. The authors say outcome-tracking studies are needed before any clinical use.
- Medium handling could become a lab skill. If RNA-based tests reach clinics, labs would need single-embryo culture, clean collection of spent medium, sample labelling and chain of custody that match the rigour of biopsy workflows.
- Open data for validation. The human RNA-seq data are public (NCBI BioProject PRJNA1072852) and the analysis code is on GitHub, so other groups can test the findings.
For clinic owners weighing PGT-A investment, our earlier report on PGT-A cost-effectiveness and public funding gives context. Any future AI or molecular embryo-ranking tool will also face the regulatory questions covered in our guide to AI embryo assessment under FDA and CDSCO.
What is the India and global angle?
The research was funded by Japan’s AMED under a project to develop non-invasive PGT-A using embryo culture medium, plus JSPS grants. In Japan, assisted reproduction accounted for about 85,000 births in 2023, roughly one in nine babies, the press release says, citing the Japan Society of Obstetrics and Gynecology.
For Indian labs nothing changes today: this work offers no test. Any future non-invasive test would need independent validation and would have to fit within the Assisted Reproductive Technology (Regulation) Act, 2021 and its rules on embryo testing. Labs that already document culture conditions and sample handling consistently, for example with our free lab QC tools, would be better placed to take part in validation studies.
What is the commercial outlook?
The paper describes no product, and the authors declare no competing interests. Next steps listed by the team include analysing the extracellular vesicles that carry the RNA, differences between types of chromosomal error, and mosaic embryos. Turning a research signature into a validated, clinic-ready test is likely to take further studies.
This article reports a research study. It is not medical advice.
Sources
- Sugimoto T, Mariya T, Kato T et al., Nature Cell Biology, “Full-length RNA sequencing profiles intracellular and extracellular RNAs in euploid and aneuploid human embryos”, published 9 Nov 2026 (peer-reviewed, Resource article). https://www.nature.com/articles/s41556-026-02123-3
- Sapporo Medical University press release (Japanese), “受精卵が培養液中に放出するRNAは、胚の染色体の状態を映し出す” [RNA released by embryos into culture medium reflects their chromosome status], Nov 2026 (institutional press release). https://web.sapmed.ac.jp/jp/news/press/e0ni6t0000000t6f.html
- Bioengineer.org (Scienmag syndication), “Sequencing Maps Cell-Free RNA Differences Across Euploid and Aneuploid Human Embryos”, 9 Nov 2026 (science news summary). https://bioengineer.org/sequencing-maps-cell-free-rna-differences-across-euploid-and-aneuploid-human-embryos/
- NCBI Sequence Read Archive, BioProject PRJNA1072852 (the study’s human RNA-seq data, public). https://www.ncbi.nlm.nih.gov/bioproject/1072852
Tags: cell-free RNA embryo culture medium, non-invasive PGT-A, niPGT, spent culture medium, euploid aneuploid blastocyst, embryo cfRNA, Nature Cell Biology IVF study, embryo selection research